naringenin has been researched along with Benign Neoplasms, Brain in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Dai, Z; Ma, Y; Song, T; Wang, Y; Wu, J; Zhang, M | 1 |
| Almaimani, RA; Almasmoum, HA; Alrobaian, M; Baothman, AA; Beg, S; Choudhry, H; Ghaith, MM; Ibrahim, IAA; Panda, SK; Shen, L; Singh, T; Wang, L; Wang, X | 1 |
| Amirkhosravi, A; Juybari, KB; Mehrabani, M; Mehrbani, M; Mirzamohammdi, S; Nematollahi, MH; Sargazi, ML; Tarzi, ME | 1 |
| Gabrani, R; Gautam, M | 1 |
| Chang, YM; Chen, CJ; Chen, KM; Chen, PN; Chen, YY; Hseu, YC; Hsu, LS; Wang, KY; Yeh, KT | 1 |
| Mahalakshmi, P; Sabarinathan, D; Vanisree, AJ | 1 |
| Sabarinathan, D; Vanisree, AJ | 1 |
7 other study(ies) available for naringenin and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo.
Topics: Animals; Apoptosis; Astrocytes; Brain Neoplasms; Caspases; Cell Proliferation; Cells, Cultured; Drug Therapy, Combination; Flavanones; Glioma; Humans; Ki-67 Antigen; Male; Mice, Nude; Rats, Sprague-Dawley; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53 | 2020 |
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Estrogen Antagonists; Female; Flavanones; Glioblastoma; Lipids; Male; Nanoparticles; Paclitaxel; Particle Size; Peptides, Cyclic; Rats; Rats, Wistar | 2021 |
Naringenin attenuates cell viability and migration of C6 glioblastoma cell line: a possible role of hedgehog signaling pathway.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Flavanones; Glioblastoma; Mice; Rats; Repressor Proteins; Signal Transduction; Smoothened Receptor; Zinc Finger Protein GLI1 | 2021 |
Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Flavanones; Glioblastoma; Humans; Temozolomide | 2022 |
Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Flavanones; Glioblastoma; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness | 2019 |
Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase 4; Flavanones; Glioma; Glutathione; Glutathione Peroxidase; Immunohistochemistry; Male; NF-kappa B; Proliferating Cell Nuclear Antigen; Protein Kinase C; Rats; Receptors, Peptide; Thiobarbituric Acid Reactive Substances; Vascular Endothelial Growth Factor A; Vitamin E | 2011 |
Plausible role of naringenin against cerebrally implanted C6 glioma cells in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cyclooxygenase 2; Flavanones; Gene Expression; Glioma; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Xenograft Model Antitumor Assays | 2013 |